Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families
- PMID: 8968102
Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families
Abstract
We analyzed 16 Italian breast and breast/ovarian cancer families for BRCA1 germline mutations using a combination of the protein truncation test (PTT) and the single-strand conformation polymorphism techniques. Genomic DNA from the affected proband of each family was analyzed by applying the PTT to exon 11 of the BRCA1 gene. This initial screening led to the identification of truncated protein products in three families that were shown to carry three different frameshift mutations. In the families that scored negative in the PTT, single-strand conformation polymorphism analysis of the entire coding sequence of the gene revealed four additional mutations consisting of one nonsense, one in-frame deletion, one frameshift, and one missense mutation (in a family with a case of male breast cancer). The four frameshift mutations resulted in a decreased expression of the mutant allele, whereas no loss of transcript was associated with the other three mutations. All mutant alleles were shown to cosegregate with the cancer phenotype within the families, and none have previously been reported.
Similar articles
-
Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families.Oncogene. 1999 Jul 15;18(28):4160-5. doi: 10.1038/sj.onc.1202754. Oncogene. 1999. PMID: 10435598
-
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.BMC Cancer. 2006 Sep 29;6:230. doi: 10.1186/1471-2407-6-230. BMC Cancer. 2006. PMID: 17010193 Free PMC article.
-
BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.Oncogene. 1996 Oct 3;13(7):1483-8. Oncogene. 1996. PMID: 8875986
-
Transcript identification in the BRCA1 candidate region.Breast Cancer Res Treat. 1995;33(2):115-24. doi: 10.1007/BF00682719. Breast Cancer Res Treat. 1995. PMID: 7749139 Review.
-
[Molecular diagnosis of hereditary cancer].Med Clin (Barc). 2000 Jul 1;115(5):190-7. doi: 10.1016/s0025-7753(00)71503-x. Med Clin (Barc). 2000. PMID: 10996877 Review. Spanish. No abstract available.
Cited by
-
Two Missense Mutations in the Primary Autosomal Recessive Microcephaly Gene MCPH1 Disrupt the Function of the Highly Conserved N-Terminal BRCT Domain of Microcephalin.Mol Syndromol. 2012 Jun;3(1):6-13. doi: 10.1159/000338975. Epub 2012 Jun 13. Mol Syndromol. 2012. PMID: 22855649 Free PMC article.
-
Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?Am J Hum Genet. 1997 Mar;60(3):486-95. Am J Hum Genet. 1997. PMID: 9042907 Free PMC article.
-
Identification of a founder BRCA2 mutation in Sardinian breast cancer families.Fam Cancer. 2007;6(1):73-9. doi: 10.1007/s10689-006-9107-7. Fam Cancer. 2007. PMID: 17216544
-
BRCA1 and BRCA2 mutations in central and southern Italian patients.Breast Cancer Res. 2000;2(4):307-10. doi: 10.1186/bcr72. Epub 2000 Mar 31. Breast Cancer Res. 2000. PMID: 11056688 Free PMC article.
-
Identification of a founder BRCA2 mutation in Sardinia.Br J Cancer. 2000 Feb;82(3):553-9. doi: 10.1054/bjoc.1999.0963. Br J Cancer. 2000. PMID: 10682665 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous